ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

1,4-フェニレン ジイソチオシアナート

p-Phenylene diisothiocyanate

HCID 19958
反応を作成
印刷
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
4044-65-9
標準SMILES
S=C=Nc1ccc(N=C=S)cc1
InChIKey
OMWQUXGVXQELIX-UHFFFAOYSA-N
分子式
C8H4N2S2
平均分子量
192.3 g/mol
単同位体質量
191.98159013

概要

Bitoscanate appears as odorless colorless crystals. Melting point 132 °C.

名称と識別子

優先名称
p-Phenylene diisothiocyanate
IUPAC
1,4-diisothiocyanatobenzene
現地名
1,4-フェニレン ジイソチオシアナート
英語名
1,4-Phenylene diisothiocyanate
分子式
C8H4N2S2
分子量
192.26

名称と別名

BITOSCANATE4044-65-9p-Phenylene diisothiocyanateBenzene, 1,4-diisothiocyanato-BitoscanatBitoscanato1,4-phenylenediisothiocyanatePhenylene thiocyanateBitoscanatumBiscomatePhenylene-1,4-diisothiocyanateBitoscanatum [Latin]
名称をさらに表示
1,4-フェニレン ジイソチオシアナートビトスカナートp-フェニレンビス(イソチオシアナート)1,4-フェニレンビスイソチオシアナートp-フェニレンジイソチオシアナート1,4-フェニレンジイソチオシアナート(1,4-フェニレン)ジイソチオシアナートジョニット1,4-ジイソチオシアナトベンゼン1,4-フェニレンジイソチオシアネートジイソチオシアン酸P-フェニレンジイソチオシアン酸 p-フェニレンベンゼン1,4-ジイソチオシアナートジイソチオシアン酸P‐フェニレン1,4-DIISOTHIOCYANATOBENZENE16842DITCPDITCJonitjonit[qr]
1,4-Phenylen-diisothiocyanatWM 842Isothiocyanic acid p-phenylene esterIsothiocyanic acid, 1,4-phenylenedi-NSC-7588846D1R3P86GXAI3-28258Isothiocyanic acid, p-phenylene ester

データベース識別子

CAS
4044-65-9
PubChem CID
19958
DTXSID
DTXSID3046532
ChEMBL
CHEMBL2104676
ChEBI
CHEBI:134845
UNII
6D1R3P86GX
EC Number
223-741-3
Nikkaji
J8.674F

物性

構造計算による物性

XLogP
4.7
極性表面積
88.9 Ų
水素結合供与体数
0
水素結合受容体数
4
回転可能結合数
2
重原子数
12
形式電荷
0
複雑度
205

実験および物理化学的性質

Chemical ClassesReactive agents - 1st degree
LogP2.8
Odor · 2 件

Odorless

Almost odorless

TasteTasteless
Color/Form · 2 件

Colorless needles

Yellowish-white, crystalline powder

Solubility · 2 件

Practically insoluble in water. Sol in alcohol, chloroform.

Soluble in acetone and acetic acid

DecompositionWhen heated to decomposition it emits very toxic fumes of /hydrogen cyanide, nitrogen and sulfur oxides/.
Melting Point · 3 件

270 °F (EPA, 1998)

132 °C

132 °C

Vapor Pressure6.2X10-5 mm Hg at 25 °C /Estimated/
Henry's Law ConstantHenry's Law constant = 1.13X10-4 atm-cu m/mole at 25 °C /Estimated/
Physical Description

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 4 件

Danger

H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]

P233, P260, P261, P264, P264+P265, P270, P271, P280, P284, P301+P316, P301+P330+P331, P302+P352, P302+P361+P354, P304+P340, P305+P351+P338, P305+P354+P338, P316, P319, P321, P330, P332+P317, P337+P317, P342+P316, P362+P364, P363, P403, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 44 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

危険有害性情報

Regulatory Information · 2 件

Benzene, 1,4-diisothiocyanato-: Does not have an individual approval but may be used under an appropriate group standard

The New Jersey Worker and Community Right to Know Act requires public and private employers to provide information about hazardous substances at their workplaces. (N.J.S.A. 34:5A-1 et. seq.)

DOT LabelPoison Corrosive
Fire HazardsWhen heated to decomposition, it emits very toxic fumes of nitrogen oxides and sulfur oxides. (EPA, 1998)
Health HazardsThis material is highly toxic if ingested. It is a central nervous system and gastrointestinal toxin in humans. (EPA, 1998)
Reactive GroupIsocyanates and Isothiocyanates
Special ReportsUSEPA; Chemical Profile: Bitoscanate (1985) http://yosemite.epa.gov/oswer/CeppoEHS.nsf/Profiles/4044-65-9?OpenDocument
Reactivity ProfileBITOSCANATE reacts readily with amines [Noller]. These reactions may generate significant amounts of heat. Emits very toxic fumes of nitrogen oxides and sulfur oxides when heated to decomposition [EPA, 1998].

化学と産業

薬理情報

Biological Half-Life · 2 件

Half-life of 0.5 and 8 days in renal elimination and fall-off of blood concentrations of half-life of 0.8 and 12 days /occurred after oral admin of bitoscanate to dogs/. /Similar results were obtained in man except that urinary excretion was more delayed, and more (14)C-bitoscanate was excreted renally/.

... a half-life of 26 days has been reported /in humans/.

Metabolism/Metabolites · 1 件

Cyanide is rapidly alsorbed through oral, inhalation, and dermal routes and distributed throughout the body. Cyanide is mainly metabolized into thiocyanate by either rhodanese or 3-mercaptopyruvate sulfur transferase. Cyanide metabolites are excreted in the urine. (L96)

Absorption, Distribution and Excretion · 2 件

After oral administration of the anthelmintic, (14)C-bitoscanate to dogs, renal elimination ... and fall-off of blood concentrations ... of (14)C- were biphasic. Similar results were obtained in man except that urinary excretion was more delayed, and more (14)C- was excreted renally. Much of the (14)C- had been excreted within 5 days from both species, but excretion of the remainder was protracted. Thus after 3 weeks, the dog had excreted 80% in the feces, and 12% in the urine, and after 5 weeks, man had excreted respectively 55 and 28% by these routes; 3% still circulated in the blood. Fetuses contained 3% of the dose, 16 hr after admin of (14)C-bitoscanate to a pregnant dog. The data indicated that part of the (14)C binding to the tissues was only slowly excreted, possibly because (14)C-bitoscanate was irreversibly bound to biological macromolecules through its isothiocyanate groups. ... final rates of excretion of (14)C reflected rates of metabolism and excretion of the endogenous macromolecules to which bitoscanate was bound.

Bitoscanate is partly absorbed from the gastro-intestinal tract and slowly excreted ...

用途と製造

Uses · 2 件

Anthelmintic

MEDICATION

Methods of Manufacturing

関連反応

1 件
反応記録を作成
HRID 1856140 の反応式
HRID 1856140反応物として

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
Bitoscanate appears as odorless colorless crystals. Melting point 132 °C.
Collision Cross Section146.59 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

物理化学的性質

融点
129 · 129-131 °C (lit.)
沸点
339.4 · 339.4±25.0 °C(Predicted)
比重(密度)
1.3675 · 1.3675 (rough estimate)
屈折率
1.6 · 1.6000 (estimate)
貯蔵温度
20 °C · −20°C
溶解性
クロロホルム:透明
外見
粉
色
白い
水溶解度
水中で加水分解します。
Merck
14 · 14,1308
BRN
2414340 · 2414340
InChI
1S/C8H4N2S2/c11-5-9-7-1-2-8(4-3-7)10-6-12/h1-4H
InChIKey
OMWQUXGVXQELIX-UHFFFAOYSA-N
SMILES
S=C=Nc1ccc(cc1)N=C=S
CAS データベース
4044 · 4044-65-9(CAS DataBase Reference)
EPAの化学物質情報
Bitoscanate (4044-65-9)

化学的性質

化学的特性off-white to yellow to beige-grey crystalline

Air and Water ReactionsNo rapid reaction with air. No rapid reaction with water.
CERCLA Reportable Quantities · 1 件

Releases of CERCLA hazardous substances are subject to the release reporting requirement of CERCLA section 103, codified at 40 CFR part 302, in addition to the requirements of 40 CFR part 355. Bitoscanate is an extremely hazardous substance (EHS) subject to reporting requirements when stored in amounts in excess of its threshold planning quantity (TPQ) of 500 or 10,000 lbs. Extremely hazardous substances that are solids are subject to either of two threshold planning quantities ... The lower quantity applies only if the solid exists in powdered form and has a particle size less than 100 microns; or is handled in solution or in molten form; or meets the criteria for a National Fire Protection Association (NFPA) rating of 2, 3 or 4 for reactivity. If the solid does not meet any of these criteria, it is subject to the upper ... threshold planning quantity ... .

Hazard Classes and Categories · 2 件

Acute Tox. 3 (100%)

Reactive agents - 1st degree

安全と保護具

Fire FightingExcerpt from ERG Guide 154 [Substances - Toxic and/or Corrosive (Non-Combustible)]:
First AidWarning: Fatalities have occurred with ingestion of as little as 300 mg of bitoscanate. Effects may be delayed.
Nonfire Spill ResponseExcerpt from ERG Guide 154 [Substances - Toxic and/or Corrosive (Non-Combustible)]:
Disposal Methods · 2 件

SRP: The most favorable course of action is to use an alternative chemical product with less inherent propensity for occupational exposure or environmental contamination. Recycle any unused portion of the material for its approved use or return it to the manufacturer or supplier. Ultimate disposal of the chemical must consider: the material's impact on air quality; potential migration in soil or water; effects on animal, aquatic, and plant life; and conformance with environmental and public health regulations.

SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.

Isolation and EvacuationExcerpt from ERG Guide 154 [Substances - Toxic and/or Corrosive (Non-Combustible)]:
Protective Action Criteria (PAC) · 3 件

1.8 [mg/m3]

20 [mg/m3]

25 [mg/m3]

Personal Protective Equipment (PPE) · 1 件

For emergency situations, wear a positive pressure, pressure-demand, full facepiece self-contained breathing apparatus (SCBA) or pressure- demand supplied air respirator with escape SCBA and a fully-encapsulating, chemical resistant suit. (EPA, 1998)

毒性情報

Treatment · 1 件

EYES: irrigate opened eyes for several minutes under running water. INGESTION: do not induce vomiting. Rinse mouth with water (never give anything by mouth to an unconscious person). Seek immediate medical advice. SKIN: should be treated immediately by rinsing the affected parts in cold running water for at least 15 minutes, followed by thorough washing with soap and water. If necessary, the person should shower and change contaminated clothing and shoes, and then must seek medical attention. INHALATION: supply fresh air. If required provide artificial respiration.

Health Effects · 1 件

Exposure to high levels of cyanide for a short time harms the brain and heart and can even cause coma, seizures, apnea, cardiac arrest and death. Chronic inhalation of cyanide causes breathing difficulties, chest pain, vomiting, blood changes, headaches, and enlargement of the thyroid gland. Skin contact with cyanide salts can irritate and produce sores. (L96, L97)

Ecotoxicity ValuesLC50 Daphnia magna (Water flea) 77 ug/L/48 hr (95% confidence interval: 70-85 ug/L); static
Exposure RoutesOral (L96) ; inhalation (L96) ; dermal (L96)
Toxicity Summary · 1 件

Cyanide is an inhibitor of cytochrome c oxidase in the fourth complex of the electron transport chain (found in the membrane of the mitochondria of eukaryotic cells). It complexes with the ferric iron atom in this enzyme. The binding of cyanide to this cytochrome prevents transport of electrons from cytochrome c oxidase to oxygen. As a result, the electron transport chain is disrupted and the cell can no longer aerobically produce ATP for energy. Tissues that mainly depend on aerobic respiration, such as the central nervous system and the heart, are particularly affected. Cyanide is also known produce some of its toxic effects by binding to catalase, glutathione peroxidase, methemoglobin, hydroxocobalamin, phosphatase, tyrosinase, ascorbic acid oxidase, xanthine oxidase, succinic dehydrogenase, and Cu/Zn superoxide dismutase. Cyanide binds to the ferric ion of methemoglobin to form inactive cyanmethemoglobin. (L97)

Signs and SymptomsCyanide poisoning is identified by rapid, deep breathing and shortness of breath, general weakness, giddiness, headaches, vertigo, confusion, convulsions/seizures and eventually loss of consciousness. (L96, L97)
Human Toxicity Excerpts/SIGNS AND SYMPTOMS/ Transient mild to moderate side effects may occur in up to half of the patients treated. They include nausea and vomiting, anorexia, abdominal pain, diarrhea, headache, and dizziness.
Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Non-Human Toxicity Excerpts · 2 件

/LABORATORY ANIMALS: Acute Exposure/ Two cholangiotoxic agents, alpha-naphthylisothiocyanate (ANIT) and p-phenylenediisothiocyanate (PDT), were administered in single doses to mice to study their effects on the gallbladder. Both compounds caused maximal bile duct necrosis and periportal hepatocytic necrosis at 24 hr. The gallbladders were edematous but not necrotic at 24 hr after treatment. At 48 hr, and in some animals up to 4 days, severe cholecystitis was present, while bile ducts revealed progressive regeneration. The delay in the onset lesions gallbladder leions was probably the result of the toxic agent concentration in gallbladder bile after hepatic bile secretion was suppressed for 24 hr. The lesions provoked by PDT were similar to those induced by ANIT, except for a hemorrhagic component.

/LABORATORY ANIMALS: Developmental or Reproductive Toxicity/ 1,4-Phenylenediisothiocyanate was given to five groups of rats of different developmental stages (97 animals in all), and the changes in the hepatobiliary system were compared histopathologically. Three groups of rats given the drug after birth showed dilation of the extrahepatic bile ducts with inflammation. Two groups given the drug during the fetal period or added after birth showed stenotic or atretic extrahepatic bile ducts due to thickening and fibrosis of the wall. ...

Environmental Abiotic DegradationBitoscanate may decompose upon exposure to water or moist air(1).
Toxicity DataLD50: 21 mg/kg (Intraperitoneal, Mouse) (T14) LD50: 230 mg/kg (Oral, Mouse) (T14)
Non-Human Toxicity Values · 3 件

LD50 Mouse ip 21 mg/kg

LD50 Mouse oral 230 mg/kg

LD50 Rat oral 21 mg/kg

法規制情報

CERCLA Reportable Quantities · 1 件

Releases of CERCLA hazardous substances are subject to the release reporting requirement of CERCLA section 103, codified at 40 CFR part 302, in addition to the requirements of 40 CFR part 355. Bitoscanate is an extremely hazardous substance (EHS) subject to reporting requirements when stored in amounts in excess of its threshold planning quantity (TPQ) of 500 or 10,000 lbs. Extremely hazardous substances that are solids are subject to either of two threshold planning quantities ... The lower quantity applies only if the solid exists in powdered form and has a particle size less than 100 microns; or is handled in solution or in molten form; or meets the criteria for a National Fire Protection Association (NFPA) rating of 2, 3 or 4 for reactivity. If the solid does not meet any of these criteria, it is subject to the upper ... threshold planning quantity ... .

安全データ

F
10-21
wgk
3
tsca
TSCA listed
rtecs
NX9150000
ridadr
UN 2811 6.1/PG 3
毒性
LD50 oral in mouse: 230mg/kg
hs_code
2930909099
risk_code
22-36/37/38-42
hazard_code
Xn,Xi
hazard_note
Irritant
safety_code
22-26-36/37
hazard_class
6.1
packing_group
II
Hazard Classifications
Acute Tox. 3 OralEye Irrit. 2Resp. Sens. 1Skin Irrit. 2STOT SE 3
ストレージクラス
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
有毒物質データの
4044-65-9(Hazardous Substances Data)
危険度評価(NFPA 704基準/消防庁データ)
人的[青]=2
· 2 件

Preparation and use as anthelmintic: FR M1652 and GB 1001314 (1963, 1965 to Hoechst).

Purification: Soeder, Laemmer, DE 1172664 (1964 to Hoechst).

General Manufacturing InformationBenzene, 1,4-diisothiocyanato-: ACTIVE
応用分野 · 3 件

用途アミノ酸配列分析用、二価性試薬。

使用Reagent for solid-phase sequencing.

一般的な説明Odorless colorless crystals. Melting point 132°C.

調製方法

純化方法Purify bitoscanate by recrystallisation from AcOH, pet ether (b 40-60o), Me2CO or aqueous Me2CO. [van der Kerk et al. Recl Trav Chim Pays-Bas 74 1262 1955, Leiber & Slutkin J Org Chem 27 2214 1962, Beilstein 13 IV 174.]

上流・下流製品情報

上流原料

二硝酸鉛(II)二硫化炭素二塩化チオカルボニル1,4-フェニレンジアミンp-アミノフェニルアミン・塩酸塩dimethyl 1,4-phenylenedicarbamodithioateイソチオシアン酸4-ニトロフェニルトリフルオロメタンスルフィン酸ナトリウムCarbamimidothioic acidクロロホルム無水酢酸4-ニトロアニリン

下流製品

1,4-フェニレンビス(2-チオ尿素)